Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 12/08 10:27:51 pm
103.74 USD   +0.98%
12/08 NASDAQ 100 MOVE : Viab, alxn
12/08 S&P 500 MOVERS : Coo, alxn
12/07 CELGENE : Long-Term Efficacy Data from the Phase III GeparSepto Stud..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales7 6709 25611 22912 96614 81717 023
EBITDA3 9864 9426 2988 1219 07410 237
Operating profit (EBIT)3 8814 8126 1777 2668 54310 085
Pre-Tax Profit (EBT)------
Net income2 0001 6021 9994 0515 4126 495
P/E ratio46,861,746,520,815,312,9
EPS ( $ )2,391,942,495,116,948,21
Dividend per Share ( $ )------
Yield------
Reference price ( $ )111.86119.76115.75106.09106.09106.09
Announcement Date01/29/2015
01:02pm
01/28/2016
12:30pm
01/26/2017
12:30pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt-7 6996 3204 495--
Finance675---3227 569
Operating income (EBITDA)3 9864 9426 2988 1219 07410 237
Leverage
(Debt/EBITDA)
-1,56x1,00x0,55x--
Capital Expenditure150286236251276293
Book Value Per Share (BVPS)8,15 $7,52 $8,48 $12,0 $18,0 $25,6 $
Cash Flow per Share3,36 $3,01 $4,95 $6,38 $8,28 $9,61 $
Announcement Date01/29/2015
01:02pm
01/28/2016
12:30pm
01/26/2017
12:30pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 83 526 M$ -
Entreprise Value (EV) 88 021 M$ 83 204 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 20,8x 15,3x
Capitalization / Revenue 6,44x 5,64x
EV / Revenue 6,79x 5,62x
EV / EBITDA 10,8x 9,17x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 8,81x 5,90x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 56,0% 57,7%
operating Leverage (Delta EBIT / Delta Sales) 1,14x 1,23x
Net Margin (Net Profit / Revenue) 31,2% 36,5%
ROA (Net Profit / Asset) 16,8% 17,7%
ROE (Net Profit / Equities) 62,5% 50,2%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,94% 1,86%
Cash Flow / Sales 38,7% 44,0%
Capital Intensity (Assets / Sales) 1,86x 2,06x
Financial Leverage (Net Debt / EBITDA) 0,55x -0,04x
EPS & Dividend